Clinical Trials on Bladder Mixed Adenocarcinoma
Total 13310 results
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
University Hospital Bispebjerg and FrederiksbergProff Dr Jürgen Popp, Leibniz Institute, IPHT, Jena, Germany; Karin Mogensen... and other collaboratorsRecruitingEndoscopic Bladder Cancer Diagnosis With RamanDenmark
-
Helwan UniversityCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins University; National Institutes of Health (NIH)WithdrawnBladder Cancer | Urothelial Carcinoma | Bladder TumorUnited States
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Velicept Therapeutics, Inc.CompletedHealthy Subjects, Overactive Bladder
-
McGill University Health Centre/Research Institute...CompletedUrinary Bladder Cancer | Bladder Cancer | Entire Ileal ConduitCanada
-
PhotocureKarl StorzCompletedIntermediate or High-risk Bladder Cancer
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingStage IV Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Stage IVB Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Ruijin HospitalNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Augusta UniversityNot yet recruitingOveractive Bladder | Overactive Bladder Syndrome
-
Association Francaise d'UrologieNot yet recruitingNon-Muscle-Invasive Bladder Cancer
-
Uro-1 MedicalRecruiting
-
Fisiocore LC,SLRecruitingOveractive Bladder SyndromeSpain
-
National Taiwan University HospitalCompleted
-
National and Kapodistrian University of AthensCompletedOveractive Bladder (OAB)Greece
-
CG Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingNon Muscle Invasive Bladder CancerUnited States, Korea, Republic of
-
Taipei Medical University Shuang Ho HospitalCompletedLower Urinary Tract Symptoms | Overactive Bladder SyndromeTaiwan
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Taiwan
-
Ataturk Training and Research HospitalUnknownOveractive Bladder SyndromeTurkey
-
Astellas Pharma IncCompleted
-
Catalan Institute of HealthCompletedOveractive Bladder Syndrome
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Poitiers University HospitalUnknown
-
University of OklahomaCompletedRefractory Overactive BladderUnited States
-
Astellas Pharma IncGlaxoSmithKlineWithdrawnOveractive Bladder (OAB)
-
UroGen Pharma Ltd.Withdrawn
-
National Taiwan University HospitalUnknownOveractive Bladder SyndromeTaiwan
-
The University of Texas Health Science Center at...CompletedInvasive Bladder Cancer Stage IIUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedIdiopathic Overactive BladderUnited Kingdom
-
National Taiwan University HospitalUnknown
-
PfizerCompletedOveractive Bladder SyndromeUnited States, Canada, Greece, Brazil, Korea, Republic of, Singapore, Poland, India, Norway, Slovakia, Spain, Belgium, Philippines, Netherlands, Sweden, Thailand, Malaysia, Germany, Colombia
-
Avera PharmaceuticalsTerminatedOveractive Bladder SyndromeNetherlands, United Kingdom
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
University of California, Los AngelesRecruitingBladder Cancer | Kidney Failure | Bladder, Neurogenic | Bladder DiseaseUnited States
-
Assiut UniversityCompletedPediatric Bladder StonesEgypt
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Medical University of WarsawUnknownBladder Tumor | Transurethral Resection | Spinal AnaesthesiaPoland
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Mayo ClinicRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Stage IIIA Bladder Cancer AJCC v8 | Stage II Bladder Cancer AJCC v8United States
-
University of MiamiTerminatedBladder Cancer | Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | Transition Cell CancerUnited States
-
Chinese PLA General HospitalBeijing GeneX Health Technology Co., LtdRecruitingMuscle-Invasive Bladder CarcinomaChina
-
Teesside UniversitySouth Tees Hospitals NHS Foundation TrustNot yet recruitingOveractive Bladder | Overactive Bladder Syndrome | Detrusor Overactivity
-
Turku University HospitalNordic Urothelial Cancer GroupRecruiting